NYSE$MPT

Medical Properties Trust Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Reported a net income of $0.25 per share and normalized FFO of $0.41 per share, demonstrating significant year-over-year growth and strategic portfolio expansions.

Medical Properties Trust reported a strong third quarter with a 24% increase in normalized FFO per share compared to the previous year. The company collected substantially all current rent and interest due from tenants, reflecting a return to pre-COVID operating conditions. MPT continued to expand its portfolio with strategic acquisitions in Germany, the United Kingdom and the United States, and anticipates closing on an investment in Colombia in the fourth quarter.

  • Net income was $0.25 per diluted share.
  • Normalized Funds from Operations (NFFO) was $0.41 per diluted share.
  • Nearly all current rent and interest due from operators expected to be collected in the fourth quarter.
  • Closed on acquisitions in Germany and the United Kingdom and an investment in Prime St. Francis Medical Center in Lynwood, CA.

Headline financials

Total Revenue

$329M

Previous: $225M+46.6%
EPS (adj)

$0.41

Previous: $0.33+24.2%
Capital Expenditures

-$3.52B

Previous: -$3.7B+4.8%
Free Cash Flow

-$3.39B

Previous: -$3.61B+6.1%
Net Income

$131M

Previous: $89.8M+46.0%
Operating Income

$173M

Previous: $19.3M+794.2%
Gross Profit

$293M

Previous: $90.7M+223.4%
Cash & Equivalents

$184M

Previous: $462M-60.2%
Total Assets

$16B

Previous: $12.5B+28.3%

Revenue & EPS history

Medical Properties Trust · Revenue · Quarterly

$329M

Q3 2020+46.6%vs Q3 2019
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Revenue by segment

Medical Properties Trust · $329M total across 4 segments · Q3 2020

  • Rent Billed
    $193M
  • Income from Financing Leases
    $52.5M
  • Straight-line Rent
    $51.1M
  • Interest and Other Income
    $32.8M

Forward guidance

MPT expects an annual run-rate of $1.09 to $1.12 per diluted share for net income and $1.68 to $1.71 per diluted share for NFFO.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+1.3%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+0.7%

Avg return

30 days after

65%

42 / 65 earnings

Positive

+17.0%

Q4 2024

Best reaction

-15.8%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.6%-4.1%-6.0%
Q4 2025+12.1%+6.1%-15.1%
Q3 2025+6.6%+1.4%+18.5%
Q1 2025-6.9%-8.0%-17.2%
Q4 2024+17.0%+18.2%+26.6%
Q3 2024+7.0%-5.2%-9.8%
Q2 2024+1.5%+2.4%+7.4%
Q1 2024+7.2%+31.2%+20.4%
Q4 2023+2.5%+6.7%+13.9%
Q3 2023+9.9%+7.2%+4.7%
Q2 2023-15.8%-20.0%-33.4%
Q1 2023+10.6%+4.9%-0.1%
Q4 2022-13.5%-15.6%-38.3%
Q3 2022+6.8%+6.5%+20.6%
Q2 2022-5.3%-4.3%-15.3%
Q1 2022+4.1%+6.3%+5.2%
Q4 2021-4.0%-5.2%-10.2%
Q3 2021+0.1%-1.2%+1.5%
Q2 2021+1.3%-1.5%-3.3%
Q1 2021-2.0%-4.1%-5.9%
Q4 2020+0.0%+1.6%-2.9%
Q3 2020+3.7%+10.9%+13.8%
Q2 2020-0.8%-1.6%-8.5%
Q1 2020+4.1%+0.5%+9.8%
Q4 2019+2.3%+3.6%+1.1%
Q3 2019+1.2%-6.8%+0.9%
Q2 2019+2.1%-0.1%+6.2%
Q1 2019+3.8%+1.2%+2.0%
Q4 2018+3.4%+1.7%+1.1%
Q3 2018+3.2%+9.9%+16.2%
Q2 2018+1.0%+3.0%+4.2%
Q1 2018+1.8%+2.0%+5.6%
Q4 2017+1.6%+1.5%+6.6%
Q3 2017+3.2%+3.9%+4.8%
Q2 2017-1.7%+0.1%+5.2%
Q1 2017+2.1%+2.5%+4.3%
Q4 2016+1.8%+1.8%-6.3%
Q3 2016-0.8%+1.3%-2.7%
Q2 2016+1.1%+2.0%-0.5%
Q1 2016+3.8%
Q4 2015-2.5%
Q3 2015-3.4%
Q2 2015-3.8%
Q1 2015+2.9%
Q4 2014+0.4%
Q3 2014+2.7%
Q2 2014-0.3%
Q1 2014-0.9%
Q4 2013-0.4%
Q3 2013-0.7%
Q2 2013-2.8%
Q1 2013-1.0%
Q4 2012+1.1%
Q3 2012+3.1%
Q2 2012+0.7%
Q1 2012-0.1%
Q4 2011-0.6%
Q4 2009-0.6%
Q3 2011-4.4%
Q2 2011+4.5%
Q1 2011+2.8%
Q4 2010+2.8%
Q3 2010+0.5%
Q2 2010+1.0%
Q1 2010+7.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro